poi_mhc poi
Skip to Main Content
hidden1hidden2

Mepilex® Border Heel dressing is the only five-layer foam heel dressing with proprietary Deep Defense Technology® – proven to prevent pressure ulcers when used in conjunction with other standard prevention protocols  1   10   3  11 .

The dressing can also be used for managing moderate- to high- exuding wounds of the heel area. It absorbs and retains exudate  4   12 and it balances moisture properly avoiding the risk of maceration  6   7 .

This recently-launched enhanced design includes new handling tabs and thicker borders, allowing easier application and patient checking  13 . The heel shape has been refined for good coverage of the high-risk heel area and the malleoli.

The enhanced design still includes Safetac® – the original less-pain contact layer with silicone adhesion. So the dressing is comfortable and confirms to the patients anatomy   4  – you can remove it easily without damaging the skin   8  . That means less pain for your patients  14.

  • Proven to prevent pressure ulcers – when used with other standard prevention protocols  1   10 
  • Proprietary Deep Defense Technology protects against the extrinsic forces - pressure, shear and friction; and manages micro-climate, the key factors responsible for pressure ulcers  3    8    4   
  • Mepilex Border with Safetac technology minimises pain during dressing changes  14 .
  • Good fluid handling capacity and retention  6   
  • Reduces risk of maceration   7   
hidden1hidden2

Further product information

When to use Mepilex Border Heel

Treatment

Mepilex® Border Heel is specifically designed to fit the heel. The five-layer absorbent foam structure effectively manages exudate and the wound environment. So you can use it in the treatment of exuding wounds such as pressure ulcers, diabetic foot ulcers, heel ulcers, traumatic wounds, and other secondary healing wounds.

Pressure ulcer prevention

Mepilex Border Heel has been proven to prevent pressure ulcers  1. You can apply the dressings prophylactically for at-risk patients  10, such as the immobile, those with poor skin perfusion and impaired skin condition, in emergency rooms, in intensive care, or before and during long surgical interventions. Scientific studies have demonstrated that Mepilex Border Heel has the ability to impact four extrinsic factors that can contribute to developing pressure ulcers: by minimising and redistributing shear, redistributing pressure, reducing friction and maintaining an optimal microclimate  1.

Note: using dressings as a prophylactic therapy does not replace the need for a comprehensive pressure ulcer prevention protocol.

How to use Mepilex Border Heel

Watch how to easily apply Mepilex Border Heel to help you achieve the best result for your patient.

Step-by-step instructions - initial application

Step-by-step instructions: reapplication

hidden1hidden2
hidden1hidden2

hidden1hidden2
hidden1hidden2

Product details

Ref. No. Description Pieces Per Inner NPC Code PIP Code
282710 Mepilex Border Heel 22 x 23 cm 10 ELA1019 -
283250 Mepilex Border Heel 18.5 x 24 cm 5 ELA651 383-1617
hidden1hidden2
hidden1hidden2

'References'

  1. Santamaria N, et al. Clinical effectiveness of a silicone foam dressing for the prevention of heel pressure ulcers in critically ill patients: Border II Trial. J Wound Care. 2015;24(8):340-345.
  2. Hahnel, E., El Genedy, M., Tomova-Simitchieva, T., Hauß, A., Stroux,A., Lechner,A., Richter,C., AkdeniziD,M., Blume-Peytavi, U., Löber, N. and Kottner, J. The effectiveness of two silicone dressings for sacral and heel pressure ulcer prevention compared with no dressings in high-risk intensive care unit patients: a randomized controlled parallel-group trial, British Journal of Dermatology, 2019, https://doi.org/10.1111/bjd.18621
  3. Levy A, et al. The biomechanical efficacy of dressings in preventing heel ulcers. J Tissue Viability. 2015;24(1) :1-11.
  4. Molnlycke Health Care. Verification test of new heel shape. Report no. 20170221-007. 21 February 2017. Data on file. Mepilex Border Heel
  5. Mölnlycke Health Care. Data on file. 2000
  6. Molnlycke Health Care. Design verification PUP16. Report no. 20170515-002. 15 May 2017. Data on file. Mepilex Border Sacrum
  7. Woo K, Coutts P.M., Price P, Harding K, Sibbald R.G. A randomised crossover investigation of pain at dressing change comparing 2 foam dressings Advances in Skin and Wound Care 2009;22(7):304-310.
  8. Meaume, S., Van De Looverbosch, D., Heyman, H., Romanelli, M., Ciangherotti, A., Charpin, S. S. A study to compare a new self-adherent soft silicone dressing with a self-adherent polymer dressing in stage II pressure ulcers. Ostomy Wound Management 2003;49(9):44-52.
  9. White, R. A multinational survey of the assessment of pain when removing dressings. Wounds UK 2008;4:14-22. Available from: http://www.wounds-uk.com/journal-articles/a-multinational-survey-of-the-assessment-of-pain-when-removing-dressings-1 [Accessed 4 February 2019]. Mepilex Border (and other dressings with Safetac) vs. dressings with traditional adhesives (adhesive foams, hydrocolloids etc.)
  10. Tayyib N, et al. Effectiveness of pressure ulcer prevention strategies for adult patients in intensive care units: a systematic review. Worldviews Evid Based Nurs 2016;13(6):432-444.
  11. World Union of Wound Healing Societies (WUWHS). Consensus Document: Role of dressings in pressure ulcer prevention. London, UK: Wounds Int; 2016.
  12. Molnlycke Health Care. External test Lab report id SMTL 00/1278/01,00/1235/01, 21 September 2000. Data on file. Mepilex Border
  13. Davies, P. User evaluation of interface dressings for pressure ulcer prevention. Mölnlycke Health Care (GMCS-2017-058). 18 April 2017. Data on file.
  14. White R. A multinational survey of the assessment of pain when removing dressings. Wounds UK. 4 (1). 2008.
Contact us